Livtencity (Maribavir)

Livtencity is a Cytomegalovirus pUL97 kinase inhibitor approved for both adults and pediatric patients (aged 12 years and older and weighing at least 35 kg) to treat post-transplant CMV infection/disease, refractory to treatment (with or without genotypic resistance) with drugs valganciclovir, ganciclovir, cidofovir or foscarnet.

Recommended Dosage: The recommended dosage for both adults and pediatric patients (aged 12 years and more and weighing minimum 35kg) is 400 mg (2 tablets of 200 mg) taken by mouth (orally) twice daily with or without meal/food. 

If Livtencity is used in conjunction with drug carbamazepine, increase the dosage of Maribavir to 800 mg twice daily. If Livtencity is used in conjunction with  phenytoin or phenobarbital, increase the dosage of Maribavir to 1,200 mg twice daily. 

• Maribavir may be responsible for antagonizing the antiviral mechanism of drugs ganciclovir and valganciclovir by blocking human CMV pUL97 kinase, needed for activation or phosphorylation of valganciclovir and ganciclovir. Use of Maribavir in conjunction with medicine valganciclovir or ganciclovir is not recommended. 
  
• Virologic failure because of resistance can emerge throughout and after therapy with Livtencity 200 mg. Virologic relapse throughout the posttreatment period typically occurred within 4 to 8 weeks after treatment interruption. Assess levels of cytomegalovirus DNA and evaluate for maribavir resistance if someone is not responding to therapy or relapses. 
  
• Use of Maribavir in conjunction with certain drugs may cause certain drug interactions, some of which may reduce therapeutic effects of medicine or side effects of concomitant drugs. Review concomitant medicines during Maribavir therapy and monitor for side effects.
  
• Maribavir 200 mg is basically metabolized by CYP3A4. Medicines that are strong inducers of CYP3A4 may scale down plasma concentrations of maribavir and may cause reduced virologic response; therefore, use of Maribavir together with these medications is not recommended, except for certain anticonvulsants. 
  
• Maribavir may increase the drug concentrations of immunosuppressant medications that are CYP3A4 or P-gp substrates where minimal concentration fluctuations may cause serious side effects (including cyclosporine, sirolimus, tacrolimus, and everolimus). immunosuppressant medicine levels should be monitored throughout therapy with Maribavir. 
  

What documents are required to import LIVTENCITY to India?

LIVTENCITY (maribavir) tablets can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patients id proof (issued by the government of India)

The order will be confirmed only after the receipt of:

• A valid prescription from Doctor
  
• Import permit if applicable

LIVTENCITY (maribavir tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Livtencity in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

IPN (Indian Pharma Network) can facilitate the supply of LIVTENCITY (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable). 

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Livtencity price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source the LIVTENCITY (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma Network offers its customers worldwide access to the best available treatment.

Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Livtencity®?

Maribavir is a Generic Name for the trade name drug Livtencity®.

What is the Manufacturer’s Name of Livtencity®?

Livtencity® is manufactured by Takeda Pharmaceuticals, Inc.

Is Livtencity® approved by the FDA?

Yes, Livtencity® is approved by the FDA. Date of first/initial approval: November 23, 2021.

What is the dosage and form of Livtencity® supplied?

Livtencity® is supplied as Tablets: 200 mg of Maribavir for oral administration. 

What are the most common side effects of Livtencity®? 

The most common side effects of Livtencity® are taste disturbance, diarrhea, nausea, vomiting, and fatigue. 

How much does Livtencity® cost in India?

The Livtencity cost in India can vary depending on certain factors. In order to buy/source this CMV medication authentically, you can Call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Livtencity®?

Store Livtencity tablets at temperature 20 to 25°C (68 to 77°F), brief exposure to 15 to 30°C (59 to 86°F) permitted. 

Is it safe to buy Livtencity® online from India?

Yes, one can buy Livtencity from India at the best price from the Indian Pharma Network (IPN) if Livtencity has not been launched or is unavailable in your respective country. We can help facilitate the Import of Livtencity.